BioLineRx (BLRX) Long-Term Debt Repayments (2013 - 2025)
BioLineRx (BLRX) posted Long-Term Debt Repayments of -$1.1 million for Q4 2025, down 1.79% on a QoQ basis from -$1.1 million in Q3 2025, and up 90.49% year-over-year from -$597943.8 in Q4 2024.
BioLineRx (BLRX) has 12 years of Long-Term Debt Repayments data on file, last reported at -$1.1 million in Q4 2025.
- In Q4 2025, Long-Term Debt Repayments rose 90.49% year-over-year to -$1.1 million; the TTM figure through Dec 2025 stood at -$4.5 million (up 68.84% YoY), while the FY2025 annual figure was -$4.5 million, up 68.84% from the prior year.
- Long-Term Debt Repayments declined to -$1.1 million in Q4 2025, from -$1.1 million in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at -$49000.0 in Q1 2023 and bottomed at -$12.0 million in Q4 2024.
- A 5-year average of -$1.4 million and a median of -$874000.0 in 2021 frame the typical range for Long-Term Debt Repayments.
- Annual changes were most pronounced in 2023 — Long-Term Debt Repayments jumped 94.53% — and 2024, when it sank 1515.65%.
- Year by year, Long-Term Debt Repayments stood at -$874000.0 in 2021, then declined by 16.7% to -$1.0 million in 2022, then climbed by 27.35% to -$741000.0 in 2023, then sank by 1515.65% to -$12.0 million in 2024, then soared by 90.49% to -$1.1 million in 2025.
- The last three Long-Term Debt Repayments figures came in at -$1.1 million (Q4 2025), -$1.1 million (Q3 2025), and -$1.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 | -1.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.14 Mn |
| Dec 31, 2025 | -1.14 Mn |
| Sep 30, 2025 | -1.12 Mn |
| Sep 30, 2025 | -1.12 Mn |
| Jun 30, 2025 | -1.12 Mn |
| Jun 30, 2025 | -1.12 Mn |
| Mar 31, 2025 | -1.12 Mn |
| Mar 31, 2025 | -1.12 Mn |
| Dec 31, 2024 | -11.97 Mn |
| Dec 31, 2024 | -11.97 Mn |
| Sep 30, 2024 | -914,000.00 |
| Sep 30, 2024 | -914,000.00 |
| Jun 30, 2024 | -782,000.00 |
| Jun 30, 2024 | -782,000.00 |
| Mar 31, 2024 | -765,000.00 |
| Mar 31, 2024 | -765,000.00 |
| Dec 31, 2023 | -741,000.00 |
| Dec 31, 2023 | -741,000.00 |
| Sep 30, 2023 | -619,000.00 |
| Sep 30, 2023 | -619,000.00 |
| Jun 30, 2023 | -134,000.00 |
| Jun 30, 2023 | -134,000.00 |
| Mar 31, 2023 | -49,000.00 |
| Mar 31, 2023 | -49,000.00 |
| Sep 30, 2022 | -1.02 Mn |
| Sep 30, 2022 | -1.02 Mn |
| Jun 30, 2022 | -917,000.00 |
| Jun 30, 2022 | -917,000.00 |
| Mar 31, 2022 | -895,000.00 |
| Mar 31, 2022 | -895,000.00 |
| Dec 31, 2021 | -874,000.00 |
| Dec 31, 2021 | -874,000.00 |
| Sep 30, 2021 | -854,000.00 |
| Sep 30, 2021 | -854,000.00 |
| Jun 30, 2021 | -834,000.00 |
| Jun 30, 2021 | -834,000.00 |
| Mar 31, 2021 | -814,000.00 |
| Mar 31, 2021 | -814,000.00 |
| Dec 31, 2020 | -795,000.00 |
| Dec 31, 2020 | -795,000.00 |
| Sep 30, 2020 | -1.01 Mn |
| Sep 30, 2020 | -1.01 Mn |
| Jun 30, 2020 | -649,000.00 |
| Jun 30, 2020 | -649,000.00 |
| Mar 31, 2020 | -682,000.00 |
| Mar 31, 2020 | -682,000.00 |
| Dec 31, 2019 | -819,000.00 |
| Dec 31, 2019 | -819,000.00 |
| Sep 30, 2019 | -23,000.00 |
| Sep 30, 2019 | -23,000.00 |
| Jun 30, 2019 | -24,000.00 |
| Jun 30, 2019 | -24,000.00 |
| Mar 31, 2019 | -23,000.00 |
| Mar 31, 2019 | -23,000.00 |
| Dec 31, 2018 | -341,000.00 |
| Dec 31, 2018 | -341,000.00 |
| Sep 30, 2018 | -23,000.00 |
| Sep 30, 2018 | -23,000.00 |
| Jun 30, 2018 | -24,000.00 |
| Jun 30, 2018 | -24,000.00 |
| Mar 31, 2018 | -23,000.00 |
| Mar 31, 2018 | -23,000.00 |
| Dec 31, 2017 | -23,000.00 |
| Dec 31, 2017 | -23,000.00 |
| Sep 30, 2017 | -23,000.00 |
| Sep 30, 2017 | -23,000.00 |
| Jun 30, 2017 | -24,000.00 |
| Jun 30, 2017 | -24,000.00 |
| Mar 31, 2017 | -23,000.00 |
| Mar 31, 2017 | -23,000.00 |
| Dec 31, 2016 | -21,000.00 |
| Dec 31, 2016 | -21,000.00 |
| Sep 30, 2016 | -24,000.00 |
| Sep 30, 2016 | -24,000.00 |
| Jun 30, 2016 | -25,000.00 |
| Jun 30, 2016 | -25,000.00 |
| Mar 31, 2016 | -23,000.00 |
| Mar 31, 2016 | -23,000.00 |
| Dec 31, 2015 | -23,000.00 |
| Dec 31, 2015 | -23,000.00 |
| Dec 31, 2013 | -1,000.00 |
| Dec 31, 2013 | -1,000.00 |
| Sep 30, 2013 | -1,000.00 |
| Sep 30, 2013 | -1,000.00 |
| Jun 30, 2013 | -14,000.00 |
| Jun 30, 2013 | -14,000.00 |
| Mar 31, 2013 | -21,000.00 |
| Mar 31, 2013 | -21,000.00 |